Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Sodium nitrite
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Medication === {{Infobox drug | IUPAC_name = | image = Natriumnitrit.png | image_class = skin-invert-image | alt = | caption = Chemical structure <!-- Clinical data --> | pronounce = | tradename = | Drugs.com = {{Drugs.com|pro|sodium-nitrite-injection}} | MedlinePlus = | pregnancy_AU = | pregnancy_AU_comment = Exempt<ref>{{Cite web | title=Therapeutic goods exempted from pregnancy categorisation {{!}} Therapeutic Goods Administration (TGA) | url=https://www.tga.gov.au/therapeutic-goods-exempted-pregnancy-categorisation | archive-url=https://web.archive.org/web/20150622174355/https://www.tga.gov.au/therapeutic-goods-exempted-pregnancy-categorisation | access-date=2024-12-25 | archive-date=2015-06-22}}</ref> | pregnancy_category= | routes_of_administration = | class = | ATC_prefix = V03 | ATC_suffix = AB08 | legal_AU = S4 | legal_AU_comment = <ref>{{cite web | title=Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017 | website=Therapeutic Goods Administration (TGA) | date=21 June 2022 | url=https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017 | access-date=30 March 2024}}</ref> | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_DE = <!-- Anlage I, II, III --> | legal_NZ = <!-- Class A, B, C --> | legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C --> | legal_US = Rx-only | legal_UN = <!-- N I, II, III, IV / P I, II, III, IV--> | legal_status = <!-- Free text --> <!-- Pharmacokinetic data --> | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = | duration_of_action = | excretion = <!-- Identifiers --> | CAS_number = 7632-00-0 | PubChem = 24269 | DrugBank = DB09112 | ChemSpiderID = 22689 | UNII = M0KG633D4F | KEGG = D05865 | synonyms = <!-- Chemical and physical data --> | Na = 1 | N =1 | O = 2 | smiles = N(=O)[O-].[Na+] | StdInChI = 1S/HNO2.Na/c2-1-3;/h(H,2,3);/q;+1/p-1 | StdInChIKey = LPXPTNMVRIOKMN-UHFFFAOYSA-M }} '''Sodium nitrite''' is used as a medication together with [[Sodium thiosulfate (medical use)|sodium thiosulfate]] to treat [[cyanide poisoning]].<ref name=WHO2008/> It is recommended only in severe cases of cyanide poisoning and has largely been replaced by use of [[hydroxocobalamin]],<ref name="UK2017">{{cite web |title=Sodium Nitrite Solution for Injection - Summary of Product Characteristics (SPC) - (eMC) |url=https://www.medicines.org.uk/emc/medicine/32282 |website=www.medicines.org.uk |access-date=15 January 2017|url-status=live |archive-url=https://web.archive.org/web/20170918184748/https://www.medicines.org.uk/emc/medicine/32282 |archive-date=18 September 2017}}</ref> a form of [[vitamin B12]], but given in much higher doses than needed nutritionally.<ref>{{cite journal | vauthors = Streitz MJ, Bebarta VS, Borys DJ, Morgan DL | title = Patterns of cyanide antidote use since regulatory approval of hydroxocobalamin in the United States | journal = American Journal of Therapeutics | volume = 21 | issue = 4 | pages = 244–249 | date = July–August 2014 | pmid = 23689094 | doi = 10.1097/MJT.0b013e31824ea656 | s2cid = 21116328}}</ref> In those who have both cyanide poisoning and [[carbon monoxide poisoning]] sodium thiosulfate by itself is usually recommended if the facility does not have sufficient [[hydroxycobalamin]].<ref>{{cite book | vauthors = Graham J, Traylor J | chapter = Cyanide Toxicity |date=2023 | chapter-url = http://www.ncbi.nlm.nih.gov/books/NBK507796/ | title = StatPearls |access-date=7 December 2023 |place=Treasure Island (FL) |publisher=StatPearls Publishing |pmid=29939573}}</ref><ref>{{cite book |vauthors=Baren JM |title=Pediatric Emergency Medicine |date=2008 |publisher=Elsevier Health Sciences |isbn=978-1416000877 |page=1018 |url=https://books.google.com/books?id=wpvux6RS-jsC&pg=PA1018 |language=en |url-status=live |archive-url=https://web.archive.org/web/20170116172656/https://books.google.ca/books?id=wpvux6RS-jsC&pg=PA1018 |archive-date=16 January 2017 |via=[[Google Books]]}}</ref> It is given by [[intravenous infusion|slow injection into a vein]].<ref name=WHO2008>{{cite book |title=WHO Model Formulary 2008 |year=2009 |isbn=9789241547659 |vauthors=((World Health Organization)) |veditors=Stuart MC, Kouimtzi M, Hill SR |hdl=10665/44053 |author-link=World Health Organization |publisher=World Health Organization |hdl-access=free |page=65}}</ref> {{chem2|NaNO2}} side effects are chiefly related to creation of methemoglobinemia and vasodilation. Side effects can include [[low blood pressure]], [[headache]], [[shortness of breath]], [[loss of consciousness]], and vomiting.<ref name=WHO2008/> Greater care should be taken in people with underlying heart disease.<ref name=WHO2008/> The patient's levels of [[methemoglobin]] should be regularly checked during treatment.<ref name=WHO2008/> While not well studied during pregnancy, there is some evidence of potential harm to the baby.<ref name=Pro2017/> Sodium nitrite works by creating methemoglobin, where the iron atom at the center of the heme group is in the oxidized ferric ({{chem2|Fe(3+)}}) state, which binds with cyanide with greater affinity than its binding to the [[cytochrome C oxidase]], and thus removes it from blocking the metabolic function of [[mitochondria]].<ref name=Pro2017>{{cite web |title=Sodium Nitrite Injection - FDA prescribing information, side effects and uses |url=https://www.drugs.com/pro/sodium-nitrite-injection.html |website=www.drugs.com |url-status=live |archive-url=https://web.archive.org/web/20170118044431/https://www.drugs.com/pro/sodium-nitrite-injection.html |archive-date=18 January 2017}}</ref> Sodium nitrite came into medical use in the 1920s and 1930s.<ref>{{cite book |vauthors=Dart RC |title=Medical Toxicology |date=2004 |publisher=[[Lippincott Williams & Wilkins]] |isbn=9780781728454 |page=172 |url=https://books.google.com/books?id=BfdighlyGiwC&pg=PA172 |language=en |url-status=live |archive-url=https://web.archive.org/web/20170116172601/https://books.google.ca/books?id=BfdighlyGiwC&pg=PA172 |archive-date=16 January 2017 |via=[[Google Books]]}}</ref><ref>{{cite book |vauthors = Bryan NS, Loscalzo J |title=Nitrite and Nitrate in Human Health and Disease |date=2011 |publisher=Springer Science & Business Media|isbn=9781607616160 |page=226 |url=https://books.google.com/books?id=CDkkwVV4aMQC&pg=PA226 |language=en |url-status=live |archive-url=https://web.archive.org/web/20170116173748/https://books.google.ca/books?id=CDkkwVV4aMQC&pg=PA226 |archive-date=16 January 2017 |via=[[Google Books]]}}</ref> It is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO21st">{{cite book |vauthors=((World Health Organization)) |title=World Health Organization model list of essential medicines: 21st list 2019 |year=2019 |hdl=10665/325771 |author-link=World Health Organization |publisher=World Health Organization |location=Geneva |id=WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO |hdl-access=free}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)